SBRA vs DOC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

SBRA

54.1
AI Score
VS
DOC Wins

DOC

60.4
AI Score

Investment Advisor Scores

SBRA

54score
Recommendation
HOLD

DOC

60score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric SBRA DOC Winner
Revenue 457.62M 1.52B DOC
Net Income 15.68M 246.45M DOC
Net Margin 3.4% 16.2% DOC
ROE 0.6% 3.1% DOC
ROA 0.3% 1.1% DOC
Total Assets 5.51B 21.68B DOC
Cash 231.58M 1.63B DOC
Debt/Equity 0.95 1.28 SBRA

Relative Price Performance (Last 90 Days)

SBRA 1M: -4.6% · 3M: -14.2% DOC 1M: -10.3% · 3M: -16.3%

Current Technical Phase

SBRA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.5%), weak momentum, RSI 39

RSI (14): 38.7 · Price: $18.90

DOC

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.2%), weak momentum, RSI 35

RSI (14): 35.1 · Price: $18.48

Fundamentals Snapshot

Metric SBRA DOC
Market Cap — —
Forward P/E 23.3 132.0
Trailing P/E 77.7 53.6
Revenue (TTM) — —
Revenue Growth 0.3% 0.1%
Gross Margin 0.5% 0.6%
Operating Margin -0.1% 0.2%
EPS 0.25 0.35
Dividend Yield 0.06% 0.07%

Frequently Asked Questions

Based on our detailed analysis, DOC is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.